Aruna Bio Overview

  • Founded
  • 2003
Founded
  • Status
  • Private
  • Employees
  • 34
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $10.8M
Latest Deal Amount
  • Investors
  • 7

Aruna Bio General Information

Description

Developer of a neural exosome platform designed to prepare medicine for the treatment of neural diseases. The company's platform harnesses the natural abilities of neural exosomes to cross the blood-brain barrier and enhance the body's anti-inflammatory, self-repair, and protective mechanisms to treat a range of neurodegenerative disorders, enabling drug manufacturers to prepare the drug for stroke, traumatic brain, and spinal cord injuries.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Drug Discovery
Primary Office
  • 184 Collins Industrial Boulevard
  • Suite A
  • Athens, GA 30601
  • United States
+1 (678) 000-0000

Aruna Bio Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aruna Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Later Stage VC 14-Apr-2021 $10.8M 000.00 Completed Pre-Clinical Trials
13. Debt - PPP 09-Apr-2020 00000 000.00 Completed Pre-Clinical Trials
12. Grant 18-Sep-2019 00.00 000.00 Completed Pre-Clinical Trials
11. Later Stage VC 24-Jul-2019 000.00 000.00 Completed Pre-Clinical Trials
10. Later Stage VC 19-Jul-2018 00.000 00.00 Completed Pre-Clinical Trials
9. Later Stage VC 28-Apr-2017 00.000 00.00 Completed Pre-Clinical Trials
8. Grant 01-Jan-2017 00000 00000 Completed Pre-Clinical Trials
7. Grant 01-Jan-2014 00000 00000 Completed Pre-Clinical Trials
6. Grant 13-Jun-2013 $1.16M $164K Completed Pre-Clinical Trials
5. Early Stage VC 06-Oct-2008 $107K $164K Completed Startup
To view Aruna Bio’s complete valuation and funding history, request access »

Aruna Bio Executive Team (7)

Name Title Board Seat Contact Info
Mark Sirgo Ph.D Chief Executive Officer & Board Member
Tracey Stice Co-Founder, Chief Operating Officer & Executive Vice President, Manufacturing and Process Development
Steven Stice Ph.D Co-Founder, Chief Scientific Officer & Board Member
Amy Doherty Corporate Controller
Ralph Kauten Advisor
You’re viewing 5 of 7 executive team members. Get the full list »

Aruna Bio Board Members (12)

Name Representing Role Since
Barry Storey Self Board Member 000 0000
Darren DeVore Aruna Bio Board Member 000 0000
Harold Ingalls Aruna Bio Board Member 000 0000
John Mangan Jr. Self Board Member 000 0000
Mark Sirgo Ph.D Aruna Bio Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Aruna Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aruna Bio Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government Minority 000 0000 000000 0
Eshelman Ventures Venture Capital Minority 000 0000 000000 0
Evolution VC Partners Venture Capital Minority 000 0000 000000 0
GRA Venture Fund Venture Capital Minority 000 0000 000000 0
Environmental Protection Agency Other 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »